Anne‐Sophie W. Møller

Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model

Łukasz Kuryk, Anne‐Sophie W. Møller, Magnus Jäderberg · OncoImmunology · 2018 · 101 citations · Full text

Medicine, Immunology, Oncology +17

Chemokine Patterns in Meningococcal Disease

Anne‐Sophie W. Møller, Anna Bjerre, Berit Brusletto et al. · The Journal of Infectious Diseases · 2005 · 87 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Complement Activation and Complement-Dependent Inflammation by<i>Neisseria meningitidis</i>Are Independent of Lipopolysaccharide

Tom Sprong, Anne‐Sophie W. Møller, Anna Bjerre et al. · Infection and Immunity · 2004 · 56 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma

Łukasz Kuryk, Anne‐Sophie W. Møller, Magnus Jäderberg · Journal of Medical Virology · 2019 · 53 citations · Full text

Life Sciences, Immunology, Oncology +17

Chimeric oncolytic Ad5/3 virus replicates and lyses ovarian cancer cells through desmoglein‐2 cell entry receptor

Łukasz Kuryk, Anne‐Sophie W. Møller · Journal of Medical Virology · 2020 · 47 citations · Full text

Medicine, Immunology, Oncology +15